Literature DB >> 1830212

Verapamil and hematoporphyrin derivative for tumour destruction by photodynamic therapy.

L Gossner1, H Wittke, A Warzecha, R Sroka, H Ernst, M Meier, C Ell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1830212      PMCID: PMC1977291          DOI: 10.1038/bjc.1991.244

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  20 in total

1.  Microvascular permeability of normal and neoplastic tissues.

Authors:  L E Gerlowski; R K Jain
Journal:  Microvasc Res       Date:  1986-05       Impact factor: 3.514

2.  Homogeneous light application and monitoring of the applied power density during PDT.

Authors:  R Sroka; C Ell; W Gottschalk; J Hengst; E Unsöld
Journal:  J Photochem Photobiol B       Date:  1989-06       Impact factor: 6.252

3.  Prospective study of cutaneous phototoxicity after systemic hematoporphyrin derivative.

Authors:  R S Wooten; K C Smith; D A Ahlquist; S A Muller; R K Balm
Journal:  Lasers Surg Med       Date:  1988       Impact factor: 4.025

4.  Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor.

Authors:  K R Weishaupt; C J Gomer; T J Dougherty
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

5.  The theory of photodynamic therapy dosimetry: consequences of photo-destruction of sensitizer.

Authors:  W R Potter; T S Mang; T J Dougherty
Journal:  Photochem Photobiol       Date:  1987-07       Impact factor: 3.421

6.  Glucose administration augments in vivo uptake and phototoxicity of the tumor-localizing fraction of hematoporphyrin derivative.

Authors:  J P Thomas; A W Girotti
Journal:  Photochem Photobiol       Date:  1989-03       Impact factor: 3.421

Review 7.  Photodynamic therapy for colorectal disease.

Authors:  H Barr; S G Bown; N Krasner; P B Boulos
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

8.  Inherent adriamycin resistance in a murine tumour line: circumvention with verapamil and norverapamil.

Authors:  S Merry; P Flanigan; E Schlick; R I Freshney; S B Kaye
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640

9.  Controlled targeting of different subcellular sites by porphyrins in tumour-bearing mice.

Authors:  G Jori; E Reddi; I Cozzani; L Tomio
Journal:  Br J Cancer       Date:  1986-05       Impact factor: 7.640

10.  Cerebral photosensitisation by haematoporphyrin derivative. Evidence for an endothelial site of action.

Authors:  M C Berenbaum; G W Hall; A D Hoyes
Journal:  Br J Cancer       Date:  1986-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.